Application of da Vinci SP for Endometrial Cancer Surgical Staging
Recruiting now
Conditions studied: Endometrial Cancer
In brief
Prospective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.
Key facts
- Study ID
- NCT07027046
- Run by
- National Cancer Institute, Naples
- People needed
- 564
- Starts
- 2025-04-03
- Expected to finish
- 2029-06-01
- Last updated by the study team
- 2025-09-19
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Histologically confirmed endometrial carcinoma (including uterine carcinosarcoma)
- Performance status (ECOG) 0 - 1
- Patients undergoing staging surgery for endometrial cancer, including but not limited to robotic hysterectomy with bilateral salpingo-oophorectomy (ovarian preservation in selected patients is not an exclusion criterion) and possible sentinel lymph node biopsy/pelvic ± para-aortic lymphadenectomy
- Signed informed consent to participate in the study
You may not qualify if…
- Patients scheduled for an additional extra-genital surgical procedure during the staging surgery for endometrial carcinoma
- Patients with anesthesiological contraindications to a minimally invasive approach
- Synchronous tumor
- Recurrence of endometrial carcinoma
- Dementia or significantly altered mental status that may impair understanding and the ability to provide informed consent
- Any reason that may interfere with regular follow-up, even if limited to the first 30 days post-surgery
Where it is running
- Istituto Nazionale Tumori | "Fondazione Pascale" — Naples, Napoli, Italy (enrolling)
- IEO - Istituto Europeo di Oncologia — Milan, Italy (enrolling)
- Istituti Fisioterapici Ospitalieri - IFO — Roma, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.